Alimentary Pharmacology & Therapeutics
Fecha de publicación: 9 May 2018
Autores:Ú. C. McMenamin, B. Hicks, P. Murchie, A. P. Thrift, H. G. Coleman, B. T. Johnston, A. J. Lee, C. R. Cardwell
Background: Proton pump inhibitors (PPIs) and histamine‐2 receptor antagonists (H2RAs) are commonly used. PPIs have been shown to promote liver cancer in rats; however, only one study has examined the association in humans.
Aims to investigate PPIs and H2RAs and risk of primary liver cancer in two large independent study populations.